A Clinical Study of ONO-1110 in Patients With Fibromyalgia
A legfontosabb adatok
- Fázis
- 2. fázis
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálat adatai
- Ki végzi
- Ono Pharmaceutical Co., Ltd.
- Azonosító
- NCT06752590
- A regiszteradat frissítve
- 2026. július 7.
- Eredeti leírás
To Evaluate the Efficacy and Safety of ONO-1110 in Patients with FibromyalgiaA teljes eredeti leírásKevesebb
A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial to Evaluate the Efficacy and Safety of ONO-1110 in Patients With Fibromyalgia
To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Fibromyalgia
Bevonási feltételek: Japanese (both sexes); Outpatient; Patients who are considered capable of understanding the study procedures and completing the pain diary and questionnaires appropriately by the investigator (sub-investigator); Patients who meet the American College of Rheumatology Fibromyalgia Criteria.
Kizáró feltételek: Patients with a past history of or concurrent neurologic diseases that may affect assessments in this study; Patients with a past history of or concurrent malignant tumor within 3 years; Patients with inflammatory arthritis, infectious arthritis, or autoimmune disease; Patients with pain other than FM that may affect assessments in this study; Patients who are pregnant, nursing, or possibly pregnant, or intending to become pregnant during the study period.